VSYS yields 1000000.00% · PFE yields 6.13%● Live data
📍 VSYS pulled ahead of the other in Year 1
Combined, VSYS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VSYS + PFE for your $10,000?
Viscount Systems, Inc., through its subsidiary, Viscount Communication and Control Systems Inc., designs, manufactures, and sells access control and security products in North America. It offers intercom and physical access control systems, and emergency communications systems for various applications, including condominium/apartment building access and intercom; residential intercom; gated home/community access and intercom; seniors/government housing access, tracking, and intercom; elevator access and tracking; garage or perimeter gate control; and emergency communications. The company's principal product is the Enterphone intercom and access control system, a patented building entry control system that uses a building's internal phone wiring to allow access control for tenants, and intercom and access control between visitors and tenants. It also manufactures electronic entry access panels that can operate using the Enterphone system or dial-up telephone company lines. In addition, the company offers Enterphone iQ, a solution based on its MESH technology; MESH, a software-based building management system; Freedom, an Internet technology platform; and Liberty, a derivation of the Freedom for the smaller sized system access control market. Viscount Systems, Inc. was founded in 1969 and is headquartered in Burnaby, Canada.
Full VSYS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.